We are live on
!
Find out more
3C
361 Capital Portfolio holdings
AUM
$213M
1-Year Est. Return
24.26%
This Fund
S&P 500
This Quarter
Est. Return
-20.52%
1 Year Est. Return
+24.26%
3 Year Est. Return
+117.64%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$220M
AUM Growth
-$141M
(-39%)
Cap. Flow
-$75.9M
Cap. Flow
% of AUM
-34.5%
Top 10 Holdings %
Top 10 Hldgs %
7.96%
Holding
421
New
120
Increased
25
Reduced
138
Closed
136
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Williams Companies
WMB
|
+$1.94M |
| 2 |
BERY
Berry Global Group, Inc.
BERY
|
+$1.81M |
| 3 |
TransUnion
TRU
|
+$1.79M |
| 4 |
RenaissanceRe
RNR
|
+$1.76M |
| 5 |
SBNY
Signature Bank
SBNY
|
+$1.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$2.21M |
| 2 |
PACCAR
PCAR
|
+$2.16M |
| 3 |
Spotify
SPOT
|
+$2.12M |
| 4 |
US Foods
USFD
|
+$2.06M |
| 5 |
ONE Gas
OGS
|
+$1.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.83% |
| 2 | Healthcare | 15.4% |
| 3 | Industrials | 12.81% |
| 4 | Financials | 12.39% |
| 5 | Real Estate | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Schwab US TIPS ETF
SCHP
$16.3B
| $2.16M | 0.98% |
75,030
+4,644
| +7% | +$133K |
|
2
Chemed
CHE
$6.78B
| $1.96M | 0.89% |
4,515
-1,322
| -23% | -$590K |
|
3
Schwab International Equity ETF
SCHF
$65.6B
| $1.86M | 0.85% |
143,962
-3,762
| -3% | -$57.9K |
|
4
Schwab Emerging Markets Equity ETF
SCHE
$12.4B
| $1.8M | 0.82% |
86,786
-4,744
| -5% | -$119K |
|
5
Cadence Design Systems
CDNS
$93.8B
| $1.74M | 0.79% |
26,300
+3,682
| +16% | +$255K |
|
6
Steris
STE
$21.3B
| $1.7M | 0.77% |
12,118
-1,580
| -12% | -$236K |
|
7
Helen of Troy
HELE
$651M
| $1.64M | 0.74% |
11,376
-1,643
| -13% | -$278K |
|
8
Cirrus Logic
CRUS
$6.83B
| $1.57M | 0.71% |
23,862
-3,372
| -12% | -$249K |
|
9
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.07B
| $1.56M | 0.71% |
53,197
+6,168
| +13% | +$186K |
|
10
FTI Consulting
FCN
$4.91B
| $1.55M | 0.7% |
12,917
+2,031
| +19% | +$239K |
|
11
Spire
SR
$4.88B
| $1.54M | 0.7% |
+20,746
| New | +$1.66M |
|
12
McKesson
MCK
$99.9B
| $1.54M | 0.7% |
+11,373
| New | +$1.67M |
|
|
BERY
13
DELISTED
Berry Global Group, Inc.
BERY
| $1.52M | 0.69% |
+49,257
| New | +$1.81M |
|
14
CACI
CACI
$10.9B
| $1.52M | 0.69% |
7,202
-1,031
| -13% | -$256K |
|
|
15
RenaissanceRe
RNR
$13.7B
| $1.47M | 0.67% |
+9,874
| New | +$1.76M |
|
16
Equity Residential
EQR
$25.3B
| $1.47M | 0.67% |
23,843
-2,203
| -8% | -$170K |
|
17
Black Hills Corp
BKH
$5.67B
| $1.44M | 0.66% |
22,515
-3,225
| -13% | -$244K |
|
|
GRMN
18
Garmin
GRMN
$46.5B
| $1.44M | 0.65% |
19,178
+7,214
| +60% | +$653K |
|
|
19
Williams Companies
WMB
$87.7B
| $1.42M | 0.64% |
+100,317
| New | +$1.94M |
|
20
AutoZone
AZO
$50.3B
| $1.39M | 0.63% |
1,645
+250
| +18% | +$260K |
|
21
Schwab US REIT ETF
SCHH
$11.7B
| $1.39M | 0.63% |
84,600
-10,558
| -11% | -$225K |
|
22
Mercury Systems
MRCY
$6.2B
| $1.37M | 0.62% |
19,183
+3,207
| +20% | +$243K |
|
|
23
TransUnion
TRU
$15.1B
| $1.37M | 0.62% |
+20,673
| New | +$1.79M |
|
24
Deckers Outdoor
DECK
$13.8B
| $1.37M | 0.62% |
61,206
-16,020
| -21% | -$446K |
|
25
Booz Allen Hamilton
BAH
$8.77B
| $1.34M | 0.61% |
19,591
-3,378
| -15% | -$249K |
|
Similar funds
SIA
PV
RCM
ALIA
TL
RI
SMFS
HF
361 Capital's Q1 2020 Portfolio in Review
As of Q1 2020, 361 Capital held 421 positions worth $220M, down 39% from $361M the previous quarter. Its ten largest holdings account for 8% of the portfolio.
361 Capital withdrew a net $75.9M in Q1 2020, closing 136 positions and reducing 138 holdings. Its most notable exit was Jazz Pharmaceuticals, an estimated $2.21M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 13% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, 361 Capital opened a new position in Williams Companies worth $1.42M.
- 361 Capital's largest Q1 2020 buy was Williams Companies: 100,317 shares worth $1.42M.
- 361 Capital added most to Huntington Ingalls Industries in Q1 2020, an estimated $1.2M increase.
- 361 Capital's biggest Q1 2020 reduction was Zebra Technologies, cutting an estimated $1.52M.
- 361 Capital fully exited Jazz Pharmaceuticals in Q1 2020, selling an estimated $2.21M.
- 361 Capital's ten largest holdings make up 8% of its $220M portfolio in Q1 2020.
- 361 Capital opened 120 new positions and closed 136 in Q1 2020.
- 361 Capital's portfolio value fell 39% quarter-over-quarter to $220M.
Based on 361 Capital's 13F filing for Q1 2020, filed 13 May 2020.